REPORT ID 16057

Global Next Generation Diabetes Therapy and Drug Delivery Market Size, Status and Forecast 2022

Publish Date
02-Oct-17
Pages
104
Format
Electronic (PDF)

This report studies the global Next Generation Diabetes Therapy and Drug Delivery market, analyzes and researches the Next Generation Diabetes Therapy and Drug Delivery development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Abbott Laboratories
    Medtronic
    Sanofi
    Novo Nordisk
    MannKind Corporation
    Enteris BioPharma
    Dexcom
    Senseonics Holding
    Medtech
    Johnson & Johnson
    Synertech
    Zosano Pharma Corp
    Relmada Therapeutics
    Eli Lilly and Company
    Transdermal Specialties

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, Next Generation Diabetes Therapy and Drug Delivery can be split into
    Inhalable Insulin
    Oral Insulin
    Insulin Patches
    CGM Systems
    Artificial Pancreas

Market segment by Application, Next Generation Diabetes Therapy and Drug Delivery can be split into
    Diagnostic/Clinics
    ICUs
    Home Healthcare

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Next Generation Diabetes Therapy and Drug Delivery Market Size, Status and Forecast 2022
1 Industry Overview of Next Generation Diabetes Therapy and Drug Delivery
    1.1  Next Generation Diabetes Therapy and Drug Delivery Market Overview
        1.1.1 Next Generation Diabetes Therapy and Drug Delivery Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Next Generation Diabetes Therapy and Drug Delivery Market by Type
        1.3.1 Inhalable Insulin
        1.3.2 Oral Insulin
        1.3.3 Insulin Patches
        1.3.4 CGM Systems
        1.3.5 Artificial Pancreas
    1.4 Next Generation Diabetes Therapy and Drug Delivery Market by End Users/Application
        1.4.1 Diagnostic/Clinics
        1.4.2 ICUs
        1.4.3 Home Healthcare

2 Global Next Generation Diabetes Therapy and Drug Delivery Competition Analysis by Players
    2.1 Next Generation Diabetes Therapy and Drug Delivery Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Abbott Laboratories
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Medtronic
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Sanofi
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Novo Nordisk
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 MannKind Corporation
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Enteris BioPharma
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Dexcom
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Senseonics Holding
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Medtech
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Johnson & Johnson
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Synertech
    3.12 Zosano Pharma Corp
    3.13 Relmada Therapeutics
    3.14 Eli Lilly and Company
    3.15 Transdermal Specialties

4 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type and Application (2012-2017)
    4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2012-2017)
    4.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2012-2017)
    4.3 Potential Application of Next Generation Diabetes Therapy and Drug Delivery in Future
    4.4 Top Consumer/End Users of Next Generation Diabetes Therapy and Drug Delivery

5 United States Next Generation Diabetes Therapy and Drug Delivery Development Status and Outlook
    5.1 United States Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
    5.2 United States Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)

6 EU Next Generation Diabetes Therapy and Drug Delivery Development Status and Outlook
    6.1 EU Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
    6.2 EU Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)

7 Japan Next Generation Diabetes Therapy and Drug Delivery Development Status and Outlook
    7.1 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
    7.2 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)

8 China Next Generation Diabetes Therapy and Drug Delivery Development Status and Outlook
    8.1 China Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
    8.2 China Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)

9 India Next Generation Diabetes Therapy and Drug Delivery Development Status and Outlook
    9.1 India Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
    9.2 India Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Development Status and Outlook
    10.1 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
    10.2 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
        11.1.2 EU Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
        11.1.4 China Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
        11.1.5 India Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
    11.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Value) by Type (2017-2022)
    11.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022)

12 Next Generation Diabetes Therapy and Drug Delivery Market Dynamics
    12.1 Next Generation Diabetes Therapy and Drug Delivery Market Opportunities
    12.2 Next Generation Diabetes Therapy and Drug Delivery Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Next Generation Diabetes Therapy and Drug Delivery Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Next Generation Diabetes Therapy and Drug Delivery Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source